Organ Preservation: Weekly Carboplatin and Taxol [paclitaxel] w/ Concurrent RT [radiotherapy] for Locally Advanced Laryngeal and Hypopharyngeal CA [head and neck cancer]

Trial Profile

Organ Preservation: Weekly Carboplatin and Taxol [paclitaxel] w/ Concurrent RT [radiotherapy] for Locally Advanced Laryngeal and Hypopharyngeal CA [head and neck cancer]

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Dec 2011 Planned End Date 1 Sep 2015 added as reported by ClinicalTrials.gov.
    • 11 Dec 2011 Planned number of patients 200 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top